Virtu KCG Holdings’s IGC Pharma IGC Stock Holding History

Virtu KCG Holdings’s Portfolio IGC Stock Details IGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$115K	Buy	281,304 +251,493	+844%	+$112K	﹤0.01%	2380
2017 Q1	$14K	Sell	29,811 -12,030	-29%	-$3.81K	﹤0.01%	3001
2016 Q4	$12K	Buy	+41,841	New	+$14.5K	﹤0.01%	3275
2016 Q2	–	Sell	-53,934	Closed	-$28K	–	3114
2016 Q1	$28K	Buy	53,934 +26,116	+94%	+$7.91K	﹤0.01%	2554
2015 Q4	$7K	Sell	27,818 -55,926	-67%	-$11.1K	﹤0.01%	3389
2015 Q3	$16K	Buy	83,744 +58,540	+232%	+$15.9K	﹤0.01%	3185
2015 Q2	$10K	Buy	+25,204	New	+$11.1K	﹤0.01%	3235
2015 Q1	–	Sell	-14,015	Closed	-$9K	–	3462
2014 Q4	$9K	Sell	14,015 -6,025	-30%	-$4.36K	﹤0.01%	3658
2014 Q3	$14K	Buy	+20,040	New	+$19.5K	﹤0.01%	3494
2014 Q1	–	Sell	-31,671	Closed	-$33K	–	3763
2013 Q4	$33K	Buy	+31,671	New	+$29.4K	﹤0.01%	3669

Other funds holding IGC

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Virtu KCG Holdings's IGC Position: Q2 2017 in Review

Virtu KCG Holdings increased its IGC Pharma (IGC) stake by 844% in Q2 2017, buying an estimated $112K and bringing the position to 281,304 shares worth $115K. The position accounts for ﹤0.01% of the portfolio, ranked #2380.

Virtu KCG Holdings first reported a position in IGC in Q4 2013 and has held it in 10 quarters since. 9 funds tracked by Wall St. Rank hold IGC as of Q2 2017.

Virtu KCG Holdings held 281,304 shares of IGC Pharma worth $115K as of Q2 2017.
Virtu KCG Holdings bought 251,493 IGC Pharma shares in Q2 2017, an estimated $112K.
IGC Pharma made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2380 holding.
Virtu KCG Holdings first reported a position in IGC Pharma in Q4 2013 and has held it in 10 quarters since.
9 funds tracked by Wall St. Rank held IGC Pharma as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.